BerGenBio ASA (OSL:BGBIO)
Norway flag Norway · Delayed Price · Currency is NOK
1.200
+0.004 (0.33%)
Aug 29, 2025, 3:22 PM CET

BerGenBio ASA Statistics

Total Valuation

BerGenBio ASA has a market cap or net worth of NOK 46.75 million. The enterprise value is -22.76 million.

Market Cap46.75M
Enterprise Value -22.76M

Important Dates

The last earnings date was Wednesday, August 20, 2025.

Earnings Date Aug 20, 2025
Ex-Dividend Date n/a

Share Statistics

BerGenBio ASA has 39.09 million shares outstanding. The number of shares has increased by 35.14% in one year.

Current Share Class 39.09M
Shares Outstanding 39.09M
Shares Change (YoY) +35.14%
Shares Change (QoQ) n/a
Owned by Insiders (%) 6.50%
Owned by Institutions (%) 5.68%
Float 23.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.65
PB Ratio 0.70
P/TBV Ratio 0.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.21
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.39

Current Ratio 4.39
Quick Ratio 4.19
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -161.26

Financial Efficiency

Return on equity (ROE) is -88.81% and return on invested capital (ROIC) is -59.49%.

Return on Equity (ROE) -88.81%
Return on Assets (ROA) -47.22%
Return on Invested Capital (ROIC) -59.49%
Return on Capital Employed (ROCE) -172.08%
Revenue Per Employee 772,143
Profits Per Employee -15.37M
Employee Count13
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.34% in the last 52 weeks. The beta is 1.20, so BerGenBio ASA's price volatility has been higher than the market average.

Beta (5Y) 1.20
52-Week Price Change -89.34%
50-Day Moving Average 1.24
200-Day Moving Average 4.18
Relative Strength Index (RSI) 50.67
Average Volume (20 Days) 90,656

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BerGenBio ASA had revenue of NOK 5.41 million and -107.58 million in losses. Loss per share was -2.75.

Revenue5.41M
Gross Profit 5.41M
Operating Income -115.30M
Pretax Income -107.58M
Net Income -107.58M
EBITDA -115.28M
EBIT -115.30M
Loss Per Share -2.75
Full Income Statement

Balance Sheet

The company has 69.51 million in cash and n/a in debt, giving a net cash position of 69.51 million or 1.78 per share.

Cash & Cash Equivalents 69.51M
Total Debt n/a
Net Cash 69.51M
Net Cash Per Share 1.78
Equity (Book Value) 67.00M
Book Value Per Share 1.71
Working Capital 66.93M
Full Balance Sheet

Cash Flow

Operating Cash Flow -137.83M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -2,133.21%
Pretax Margin -1,990.45%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BerGenBio ASA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -35.14%
Shareholder Yield n/a
Earnings Yield -230.14%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date May 30, 2024
Split Type Reverse
Split Ratio 0.01

Scores

BerGenBio ASA has an Altman Z-Score of 4.51 and a Piotroski F-Score of 1.

Altman Z-Score 4.51
Piotroski F-Score 1